40 - 80
The TemPo Studies are evaluating the efficacy and safety of the investigational drug in two different groups of patients:
· People with early-stage PD (diagnosis within the past 3 years) who are not currently taking levodopa or dopamine agonists to manage symptoms
· People who are currently taking levodopa to manage PD symptoms
Based on your medical history, the study doctor will determine whether you may be eligible to participate in one of the TemPo Studies.
If you are interested in participating in the TemPo Studies, you will be asked to first read and sign an Informed Consent Form. This form contains information about the TemPo Studies, including a summary of what you may expect during study participation, potential risks and benefits, the rights of study participants, and other options that may be available to you. Once you have read and signed the Informed Consent Form, your study participation will begin.
As a study participant there is no guarantee that you will receive any benefits from being in this study. However, the information gathered through your participation may help researchers learn new things about the investigational drug, which could potentially benefit future generations of people affected by PD.
40 - 80